Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Future Trajectory | Learn about Veeva's growth drivers, including Crossix segment success and potential expansion beyond life sciences, with analyst price targets ranging from $270 to $330 |
Market Dynamics | Delve into Veeva's competitive landscape, including its expanding Vault CRM platform and the challenges posed by Salesforce in the CRM space |
Financial Fortitude | Explore Veeva's robust financial health, with analysts projecting 13% CAGR over three years and impressive free cash flow margins exceeding 40% |
Cloud Leader's Edge | Veeva Systems dominates life sciences cloud solutions with strong financials, strategic partnerships, and AI integration, positioning for accelerated growth |

Metrics to compare | VEEV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVEEVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 30.1x | 20.8x | −0.5x | |
PEG Ratio | 1.10 | −0.99 | 0.00 | |
Price / Book | 3.8x | 2.4x | 2.6x | |
Price / LTM Sales | 8.6x | 1.5x | 3.2x | |
Upside (Analyst Target) | 72.9% | 30.0% | 47.6% | |
Fair Value Upside | Unlock | 38.1% | 6.1% | Unlock |